Get Level 2

Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. Beximco Pharma Share Price
  4. Beximco Pharma Share Regulatory News
  5. Re: Salman Rahman

Pin to quick picksBeximco Pharma Regulatory News (BXP)

Beximco Pharma Information

Share Price Information for Beximco Pharma (BXP)

Share Price is delayed by 15 minutes
Get Live Data
50.00    0.00 (0.00%)
Bid:
45.00
Ask:
55.00
Spread: 10.00 (22.222%)
Market Cap: £223.06m
BXP Live PriceLast checked at - London Stock Exchange

Intraday Beximco Pharma Share Chart

Re: Salman Rahman

28 Aug 2008 13:50

RNS Number : 2251C
Beximco Pharmaceuticals Ltd
28 August 2008
Β 

ο»Ώ

BEXIMCO PHARMACEUTICALS LTD.

28thΒ August 2008

Salman RahmanΒ ReleasedΒ from Detention

Beximco Pharmaceuticals Ltd. (the "Company") announces thatΒ Mr.Β SalmanΒ FΒ Rahman, Vice-Chairman of the CompanyΒ has beenΒ releasedΒ fromΒ detention.Β HeΒ wasΒ initiallyΒ detainedΒ underΒ theΒ Special Powers ActΒ onΒ 5Β FebruaryΒ 2007. The honourable High Court ofΒ Bangladesh grantedΒ bail to Mr. Rahman and he wasΒ subsequentlyΒ released on 27Β August 2008.Β 

For further enquiries please contact:

Beximco Pharma

Nazmul Hassan, CEO

Tel: +880 2 861 9151, ext.2080

Libertas Capital

Aamir Quraishi/Andrew HardyΒ 

Tel: +44 (0)20 7569 9650

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
MSCLVLFLVVBZBBQ
1234567
Date   Source Headline
26th Jun 20267:30 amRNSRestoration - Beximco Pharmaceuticals PLC
26th Jun 20267:00 amRNSResults for the year ended 30 June 2025
24th Jun 20267:05 amRNSNotification of Preliminary Results and AGM
24th Jun 20267:04 amRNSQ3 Financial Results 2025-26
24th Jun 20267:03 amRNSHalf Year Results 2025-26
24th Jun 20267:02 amRNSQ1 Financial Results 2025-26
24th Jun 20267:01 amRNSQ3 Financial Results 2024-25
24th Jun 20267:00 amRNSFinancial Results from 1 Jan 25 to 31 Mar 26
22nd Jun 202611:04 amRNS-RFirst patients access affordable CF medicine
5th Mar 20269:13 amRNSUpdate on Writ Petitions
28th Jan 20262:01 pmRNSOrder re Extension to Publish Financial Results
2nd Jan 20267:30 amRNSSuspension - Beximco Pharmaceuticals PLC
2nd Jan 20267:30 amRNSSuspension - Beximco Pharmaceuticals PLC
19th Dec 202511:00 amRNSDelay in Results & Temporary Suspension
19th Dec 202511:00 amRNSDelay in Results & Temporary Suspension
13th Nov 20254:00 pmRNSRequest of Extension to Publish Q1 Results
4th Nov 20257:00 amRNSChange of Name to Beximco Pharmaceuticals PLC.
27th Oct 20253:53 pmRNSRequest of Extension to Publish Financial Results
24th Oct 20257:00 amRNS-RAffordable treatment option for cystic fibrosis
15th Sep 20251:17 pmRNSFurther update on BSEC Order
21st May 20253:18 pmRNSUpdate on BSEC Order
28th Apr 20257:00 amRNSRequest of Extension to Publish Q3 Results
21st Mar 20253:51 pmRNSResponse to media reports and update on BSEC order
6th Mar 20257:00 amRNSUpdate on BSEC order
30th Jan 20252:59 pmRNSPayment of Cash Dividend
29th Jan 20257:01 amRNSBoard Changes
29th Jan 20257:00 amRNSHalf Year Results 2024-25
14th Jan 202511:24 amRNSBoard of Directors
30th Dec 20247:00 amRNSAnnual General Meeting Statement
19th Nov 20247:00 amRNSAGM Notification
14th Nov 20247:00 amRNSFinancial Results for the First Quarter
12th Nov 202410:00 amRNSRestoration - Beximco Pharmaceuticals Limited
12th Nov 202410:00 amRNSUpdate on Interim Order Supreme Court decision
11th Nov 202411:01 amRNSFurther re the Temporary Suspension of Trading
11th Nov 20247:30 amRNSSuspension - Beximco Pharmaceuticals Limited
7th Nov 20247:00 amRNSResults for the year ended 30 June 2024
29th Oct 20247:00 amRNSNotification of Preliminary Results and AGM
28th Oct 20242:35 pmRNSUpdate on Writ Petition and Interim Order
2nd Oct 20247:00 amRNSUpdate on Writ Petition and Interim Order
30th Sep 20247:06 amRNSClarification on Writ Petition
6th Sep 20242:17 pmRNSUpdate regarding Vice-Chairman, Salman Rahman
3rd Sep 20241:45 pmRNSCorrection and Clarification of Press Commentary
15th Aug 20247:00 amRNSStatement regarding Vice-Chairman, Salman Rahman
13th Aug 20247:00 amRNSStatement on political and business situation
30th Apr 20247:00 amRNSQ3 Financial Results
4th Mar 20247:00 amRNSAppointment of Managing Director
30th Jan 20247:00 amRNSHalf Year Results 2023-24
25th Jan 20249:53 amRNSPayment of Cash Dividend
11th Jan 202411:44 amRNSBoard Change
28th Dec 20239:40 amRNSAGM Statement
1234567

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
MIG
MIG.L
LSE
0.00%
GNK
Greene King
LSE
0.00%
GFS
GFS.L
LSE
0.00%
ALFA
Alfa Financial Software Holdings
LSE
0.39%
PGH
Personal Group
LSE
0.00%
Trending
GGP
Greatland Resources
LSE
-1.71%
OMI
Orosur Mining
LSE
-2.74%
EMH
European Metals Holdings
LSE
0.00%
ALRT
Defence Holdings
LSE
-5.98%
88E
88 Energy
LSE
-2.27%